These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 4580610)
61. Desopimon in the management of obesity associated with heart disease. Gonda F; Kenedi I Ther Hung; 1973; 21(2):82-4. PubMed ID: 4792883 [No Abstract] [Full Text] [Related]
62. [Experience with a Hungarian-made chlorphentermine-type anorexigenig preparation (Desopimon) in the treatment of hypothalamopathies]. Takács L; Pethö B Orv Hetil; 1969 Mar; 110(10):540-2. PubMed ID: 5779971 [No Abstract] [Full Text] [Related]
63. New treatment for obesity: dexfenfluramine (Redux). Bihm B Medsurg Nurs; 1996 Oct; 5(5):360-2, 373. PubMed ID: 8981871 [No Abstract] [Full Text] [Related]
64. [Drug treatment of obesity]. Meinders AE; Toornvliet AC; Pijl H Ned Tijdschr Geneeskd; 1996 Aug; 140(32):1632-4. PubMed ID: 8815403 [No Abstract] [Full Text] [Related]
65. [Treatment of exogenous obesity: use of delayed action dimethylphenethylamine]. Turatti S; de Netto GA Rev Bras Med; 1970 Jan; 27(1):57-63. PubMed ID: 5517811 [No Abstract] [Full Text] [Related]
66. [Treatment of exogenous obesity: use of delayed action dimethylphenethylamine]. Turatti S; de Netto GA Rev Bras Med; 1970 Jan; 27(1):56-63. PubMed ID: 5517810 [No Abstract] [Full Text] [Related]
67. Dexfenfluramine. Spollett G Lippincotts Prim Care Pract; 1997; 1(3):320-3. PubMed ID: 9238953 [No Abstract] [Full Text] [Related]
68. [Treatment of obesity with a new lipolytic and anorexigenic drug: phenproporex]. Luquero Campos F Rev Esp Enferm Apar Dig; 1971 Apr; 34(1):91-8. PubMed ID: 5564856 [No Abstract] [Full Text] [Related]
69. Treatment of refractory obesity with fenfluramine. Munro JF; Seaton DA; Duncan LJ Br Med J; 1966 Sep; 2(5514):624-5. PubMed ID: 5331182 [No Abstract] [Full Text] [Related]
70. [Study of the action of concentrated lucofen with prolonged effect]. Godefroy G; Napolier A; Andriambao-Damasy S Mars Med; 1968; 105(3):289-93. PubMed ID: 5739899 [No Abstract] [Full Text] [Related]
74. Anti-lipaemic effect of Desopimon in obesity and in diabetes mellitus accompanied by obesity. Less E Ther Hung; 1974; 22(1):27-31. PubMed ID: 4844928 [No Abstract] [Full Text] [Related]
75. Clinical aspects of the treatment of obesity by drugs: a review. Munro JF Int J Obes; 1979; 3(2):171-80. PubMed ID: 393645 [TBL] [Abstract][Full Text] [Related]
76. Long-term drug treatment of obesity in a private practice setting. Atkinson RL; Blank RC; Schumacher D; Dhurandhar NV; Ritch DL Obes Res; 1997 Nov; 5(6):578-86. PubMed ID: 9449143 [TBL] [Abstract][Full Text] [Related]
78. [The role of anorexigenics in the treatment of obesity]. Laroche C; Boissonnas A Therapie; 1979; 34(2):181-95. PubMed ID: 386556 [No Abstract] [Full Text] [Related]
79. Comparison of a new anorectic agent AN 448 with fenfluramine in the treatment of refractory obesity. Goldrick RB; Nestel PJ; Havenstein N Med J Aust; 1974 Jun; 1(22):882-5. PubMed ID: 4604249 [No Abstract] [Full Text] [Related]
80. [Therapy of obesity using appetite depressants]. Ikeda Y Nihon Naika Gakkai Zasshi; 1995 Aug; 84(8):1290-4. PubMed ID: 7594950 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]